X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8658) 8658
Publication (1150) 1150
Book Review (113) 113
Book Chapter (57) 57
Conference Proceeding (25) 25
Dissertation (10) 10
Newspaper Article (3) 3
Streaming Video (3) 3
Magazine Article (2) 2
Web Resource (2) 2
Data Set (1) 1
Government Document (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5237) 5237
index medicus (3849) 3849
animals (3352) 3352
immunology (3273) 3273
ctla-4 antigen (3066) 3066
ctla-4 (2702) 2702
female (2408) 2408
mice (2316) 2316
male (2098) 2098
immunotherapy (2089) 2089
antigens, cd (1715) 1715
oncology (1663) 1663
abatacept (1527) 1527
cancer (1456) 1456
t cells (1401) 1401
immunoconjugates (1358) 1358
expression (1288) 1288
t-lymphocytes - immunology (1270) 1270
lymphocytes (1261) 1261
ctla-4 protein (1220) 1220
middle aged (1187) 1187
adult (1179) 1179
melanoma (1127) 1127
ipilimumab (999) 999
lymphocytes t (985) 985
activation (964) 964
antigens (926) 926
cd28 (901) 901
ctla-4 antigen - immunology (881) 881
antibodies, monoclonal - therapeutic use (851) 851
lymphocyte activation (829) 829
ctla-4 blockade (819) 819
dendritic cells (815) 815
antigens, differentiation - genetics (814) 814
mice, inbred c57bl (782) 782
aged (768) 768
ctla-4 antigen - antagonists & inhibitors (744) 744
t-lymphocytes, regulatory - immunology (740) 740
t-cells (739) 739
antigens, differentiation - immunology (724) 724
metastatic melanoma (712) 712
research (698) 698
tumors (683) 683
care and treatment (665) 665
in-vivo (665) 665
antigens, cd - immunology (662) 662
chemical and pharmacologic phenomena (659) 659
autoimmunity (658) 658
mice, inbred balb c (655) 655
medicine, research & experimental (644) 644
article (642) 642
pd-1 (638) 638
cytotoxicity (623) 623
flow cytometry (618) 618
ctla-4 antigen - genetics (610) 610
regulatory t-cells (609) 609
cd4-positive t-lymphocytes - immunology (607) 607
analysis (600) 600
immunotherapy - methods (592) 592
genetic aspects (589) 589
genetic predisposition to disease (589) 589
antigens, cd - genetics (567) 567
cells, cultured (556) 556
cell biology (536) 536
immune checkpoint (533) 533
neoplasms - immunology (531) 531
transplantation (528) 528
gene expression (523) 523
immune system (519) 519
antigen (515) 515
apoptosis (515) 515
genotype (514) 514
ctla-4 antigen - metabolism (513) 513
costimulation (502) 502
immune response (502) 502
susceptibility (496) 496
cytokines (492) 492
induction (479) 479
antigens, cd - metabolism (476) 476
receptor (475) 475
blockade (471) 471
health aspects (465) 465
antigens, differentiation - metabolism (463) 463
programmed cell death 1 receptor - antagonists & inhibitors (460) 460
melanoma - drug therapy (458) 458
disease (457) 457
tolerance (448) 448
lymphocyte activation - immunology (447) 447
b7-2 antigen (444) 444
patients (440) 440
hemic and immune systems (431) 431
antibodies (428) 428
case-control studies (427) 427
multidisciplinary sciences (426) 426
polymorphism, single nucleotide (425) 425
cd28 antigens - immunology (423) 423
cd8-positive t-lymphocytes - immunology (423) 423
responses (421) 421
biochemistry & molecular biology (417) 417
ligands (416) 416
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8395) 8395
Chinese (102) 102
Japanese (55) 55
French (45) 45
German (40) 40
Polish (18) 18
Spanish (12) 12
Korean (8) 8
Russian (8) 8
Czech (7) 7
Danish (4) 4
Hungarian (4) 4
Finnish (2) 2
Turkish (2) 2
Hebrew (1) 1
Italian (1) 1
Norwegian (1) 1
Portuguese (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 12/2013, Volume 8, Issue 12, p. e83139
CD28, CTLA-4 and PD-L1, the three identified ligands for CD80/86, are pivotal positive and negative costimulatory molecules that, among other functions,... 
IN-VITRO | ACTIVATION | HOMEOSTASIS | DENDRITIC CELLS | TOLERANCE | MULTIDISCIPLINARY SCIENCES | EXTRINSIC CONTROL | ANTI-CD28 ANTIBODY | UP-REGULATION | CUTTING EDGE | LYMPHOCYTES | B7-1 Antigen - antagonists & inhibitors | Cell Communication - immunology | B7-2 Antigen - genetics | B7-1 Antigen - genetics | Dendritic Cells - immunology | Humans | Molecular Targeted Therapy | T-Lymphocytes, Regulatory - immunology | T-Lymphocytes, Cytotoxic - drug effects | CD28 Antigens - genetics | Protein Binding - drug effects | CD28 Antigens - antagonists & inhibitors | T-Lymphocytes, Regulatory - cytology | Dendritic Cells - drug effects | B7-2 Antigen - immunology | T-Lymphocytes, Cytotoxic - immunology | Gene Expression | B7-2 Antigen - antagonists & inhibitors | B7-1 Antigen - immunology | Antibodies, Monoclonal - pharmacology | CTLA-4 Antigen - genetics | CD28 Antigens - immunology | CTLA-4 Antigen - immunology | B7-H1 Antigen - genetics | B7-H1 Antigen - immunology | Cell Movement - drug effects | T-Lymphocytes, Regulatory - drug effects | B7-H1 Antigen - antagonists & inhibitors | Lymphocyte Activation - drug effects | Cell Communication - drug effects | Dendritic Cells - cytology | CTLA-4 Antigen - antagonists & inhibitors | T-Lymphocytes, Cytotoxic - cytology | Viral antibodies | Antibodies | Antigens | B cells | T cells | Motility | Transplants & implants | Calcium | Blocking antibodies | Homeostasis | Effector cells | Reversing | Immunological synapses | Lymphocytes T | Kinases | CD28 antigen | T-cell receptor | CTLA-4 protein | Cell activation | Immunology | Lymphocytes | Dwell time | Cell cycle | Cytokines | Immunoregulation | CD80 antigen | T cell receptors | Costimulator | Microscopy | Antigen-presenting cells | PD-L1 protein | Ligands | Cell migration | Synapses | Apoptosis | Life Sciences | Human health and pathology
Journal Article
Journal Article
Science, ISSN 0036-8075, 02/2018, Volume 359, Issue 6375, pp. 582 - 587
CD8(+) T cell-dependent killing of cancer cells requires efficient presentation of tumor antigens by human leukocyte antigen class I (HLA-I) molecules.... 
HIV-1 | METASTATIC MELANOMA | CTLA-4 BLOCKADE | THERAPY | PD-1 BLOCKADE | MULTIDISCIPLINARY SCIENCES | MUTATIONAL LANDSCAPE | RESISTANCE | IDENTIFICATION | HISTOCOMPATIBILITY ANTIGENS | MOLECULES | Immunotherapy - methods | Humans | Middle Aged | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Young Adult | Cancer Vaccines - therapeutic use | Antigen Presentation | Melanoma - genetics | Skin Neoplasms - mortality | Adult | Skin Neoplasms - immunology | Skin Neoplasms - therapy | Antigens, Neoplasm - immunology | Treatment Outcome | Histocompatibility Antigens Class I - genetics | Histocompatibility Antigens Class I - chemistry | Cancer Vaccines - immunology | Melanoma - immunology | Skin Neoplasms - genetics | Protein Conformation | Aged | CD8-Positive T-Lymphocytes - immunology | CTLA-4 Antigen - antagonists & inhibitors | Melanoma - therapy | Genetic Carrier Screening | Cohort Studies | Melanoma - mortality | Care and treatment | Histocompatibility antigens | Immunotherapy | HLA histocompatibility antigens | Genotype | Genetic aspects | Health aspects | Cancer | Peptides | CD8 antigen | Genes | Molecular dynamics | Cytotoxicity | Lymphocytes T | Vaccines | Homozygosity | Cancer vaccines | Cell recognition | Genotype & phenotype | Lymphocytes | Genotypes | Immune system | Antigen presentation | Antigens | Melanoma | Epitopes | Patients | Survival | Loci | Heterozygosity | White blood cells | Immune checkpoint | Cell death | Antigen (tumor-associated) | Loss of heterozygosity | Histocompatibility antigen HLA | Mutation | Recognition | Apoptosis
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 54, pp. 139 - 148
Journal Article
Trends in Immunology, ISSN 1471-4906, 2011, Volume 32, Issue 9, pp. 428 - 433
Journal Article